(Alliance News) - The board of directors of Esprinet Spa on Tuesday approved the consolidated financial statements as of December 31, 2023, which closed with a loss of EUR11.9 million, compared to EUR47.3 million in 2022.

ROCE stood at 6.9 percent, compared to 13.3 percent in 2022.

In 2023, revenue from contracts with customers stood at EUR3.98 billion, marking a 15 percent decrease from the previous year's result, when it was EUR4.68 billion.

Gross trade margin is EUR220.8 million, down 10 percent from 2022 qihen it was EUR244.3 million. "The effect of the percentage margin increase is 5.54 percent in 2023 versus 5.22 percent in the previous year.

Ebit is EUR14.0 million, down 80 percent from EUR70.7 million in 2022.

Net financial position is positive EUR15.5 million, an improvement from both September 30, 2023 - when it was negative EUR260.6 million - and December 31, 2022, when it was negative EUR83.0 million.

Esprinet's stock closed Tuesday up 0.8 percent to EUR4.98 per share.

By Maurizio Carta, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2024 Alliance News IS Italian Service Ltd. All rights reserved.